Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases

References

• WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: Actions for impact. Available from: https://www.who.int/publications/i/item/9789240027077
   Google Scholar
• Huang P, Zhu LG, Zhu YF, et al. Seroepidemiology of hepatitis B virus infection and impact of vaccination. World J Gastroenterol. 2015;21(25):1–7. doi: 10.3748/wjg.v21.i25.7842.
   PubMed Web of Science ®Google Scholar
• Lee BS, Cho YK, Jeong SH, et al. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol. 2013;85(8):1327–1333. doi: 10.1002/jmv.23594.
   PubMed Web of Science ®Google Scholar
• Ang LW, Cutter J, James L, et al. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review. Vaccine. 2013;32(1):103–110. doi: 10.1016/j.vaccine.2013.10.057.
   PubMed Web of Science ®Google Scholar
• Nardone A, Anastassopoulou CG, Theeten H, et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect. 2009;137(7):961–969. doi: 10.1017/S0950268808001672.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu S, Tang L, et al. Analysis of pathological data of renal biopsy at one single center in China from 1987 to 2012. Chin Med J. 2014;127(9):1715–1720. doi: 10.3760/cma.j.issn.0366-6999.20132765.
   PubMed Web of Science ®Google Scholar
• Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66(3):920–923. doi: 10.1111/j.1523-1755.2004.00837.x.
   PubMed Web of Science ®Google Scholar
• Khedmat H, Taheri S. Hepatitis B virus-associated nephropathy: an international data analysis. Iran J Kidney Dis. 2010;4(2):101–105.
   PubMed Web of Science ®Google Scholar
• Zhang L, Meng H, Han X, et al. The relationship between HBV serum markers and the clinicopathological characteristics of hepatitis B virus-associated glomerulonephritis (HBV-GN) in the northeastern Chinese population. Virol J. 2012;9(1):200. doi: 10.1186/1743-422X-9-200.
   PubMedGoogle Scholar
• Li D, Gao G, Jiang H, et al. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients. Eur J Gastroenterol Hepatol. 2015;27(1):65–69. doi: 10.1097/MEG.0000000000000236.
   PubMed Web of Science ®Google Scholar
• Kong D, Wu D, Wang T, et al. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection. Int J Infect Dis. 2013;17(7):e535–e538. doi: 10.1016/j.ijid.2013.01.017.
   PubMed Web of Science ®Google Scholar
• Liu T, Yang S, Yue Z, et al. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritis. J Clin Virol. 2015;66:1–5. doi: 10.1016/j.jcv.2015.02.012.
   PubMed Web of Science ®Google Scholar
• Tan Z, Fang J, Lu JH, et al. HBV serum and renal biopsy markers are associated with the clinicopathological characteristics of HBV-associated nephropathy. Int J Clin Exp Pathol. 2014;7:8150–8154.
   PubMed Web of Science ®Google Scholar
• Medicine TEBoJoI. Summary of the forum about hepatitis B virus associated glomerulonephritis. Chin J Intern Med. 1990;29:519.
   Google Scholar
• Churg J, Bj, Glassock RJ. Renal disease: classification and atlas of glomerular disease. 2nd ed. New York (NY): Ikagu-Shoin. 1995.
   Google Scholar
• Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562. doi: 10.1038/ki.2010.462.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-Mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1–S130. doi: 10.1038/ki.2009.188.
   Google Scholar
• Zhiqiang G, Zhaohui D, Qinhuan W, et al. Cost of chronic hepatitis B infection in China. J Clin Gastroenterol. 2004;38(10 Suppl 3):S175–S178. doi: 10.1097/00004836-200411003-00010.
   PubMed Web of Science ®Google Scholar
• Lin CY. Hepatitis B virus-associated membraneous ­nephropathy: clinical features, immunological profiles and outcome. Nephron. 1990;55(1):37–44. doi: 10.1159/000185916.
   PubMed Web of Science ®Google Scholar
• Zhou SD, Zy Guo MY, Fang LJ, et al. The study of the significance of the appearance of HbcAg in glomerulonephritis. Chin J Nephrol. 1995;11:104.
   Google Scholar
• Lai KN, Li PK, Lui SF, et al. Membranous nephropathy ­related to hepatitis B virus in adults. N Engl J Med. 1991;324(21):1457–1463. doi: 10.1056/NEJM199105233242103.
   PubMed Web of Science ®Google Scholar
• Coovadia HM, Adhikari M, Morel-Maroger L. Clinico-pathological features of the nephrotic syndrome in South African children. Q J Med. 1979;48(189):77–91.
   PubMedGoogle Scholar
• Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1(8383):921–926. doi: 10.1016/s0140-6736(84)92388-2.
   PubMed Web of Science ®Google Scholar
• Takekoshi Y, Tanaka M, Shida N, et al. Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet. 1978;2(8099):1065–1068. doi: 10.1016/s0140-6736(78)91801-9.
   PubMed Web of Science ®Google Scholar
• Tadokoro M. The clinico-pathological studies of hepatitis B virus nephropathy in adults. Nihon Jinzo Gakkai Shi. 1991;33(3):257–266.
   PubMedGoogle Scholar
• Hsu HC, Lin GH, Chang MH, et al. Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol. 1983;20(3):121–129.
   PubMed Web of Science ®Google Scholar
• Slusarczyk J, Michalak T, Nazarewicz-de Mezer T, et al. Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children. Am J Pathol. 1980;98(1):29–43.
   PubMed Web of Science ®Google Scholar
• Lai KN, Lai FM, Chan KW, et al. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med. 1987;63(240):323–333.
   PubMedGoogle Scholar
• Jiang W, Liu LQ. Effect of content of hepatitis B virus DNA in the serum on the pathologic change in hepatitis B virus associated-glomerulonephritis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008;33(9):857–860.
   PubMedGoogle Scholar
• Jiang W, Liu T, Dong H, et al. Relationship between serum DNA replication, clinicopathological characteristics and prognosis of hepatitis B virus-associated glomerulonephritis with severe proteinuria by lamivudine plus adefovir dipivoxil combination therapy. Biomed Environ Sci. 2015;28:206–213.
   PubMed Web of Science ®Google Scholar
• Beck LH, Bonegio RGB, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. doi: 10.1056/NEJMoa0810457.
   PubMed Web of Science ®Google Scholar
• Qin W, Beck LH, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137–1143., doi: 10.1681/ASN.2010090967.
   PubMed Web of Science ®Google Scholar
• Xie Q, Li Y, Xue J, et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol. 2015;41(4-5):345–353. doi: 10.1159/000431331.
   PubMed Web of Science ®Google Scholar
• Gunnarsson I, Schlumberger W, Rönnelid J. Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupusnephritis. Am J Kidney Dis. 2012;59(4):585–586. doi: 10.1053/j.ajkd.2011.10.044.
   PubMed Web of Science ®Google Scholar
• Lönnbro-Widgren J, Ebefors K, Mölne J, et al. Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy. Clin Kidney J. 2015;8(4):433–439. doi: 10.1093/ckj/sfv049.
   PubMedGoogle Scholar
• Jiang Z, Cai M, Dong B, et al. Clinicopathological features of atypical membranous nephropathy with unknown ­etiology in adult Chinese patients. Medicine. 2018;97(32):32(e11608. doi: 10.1097/MD.0000000000011608.
   Web of Science ®Google Scholar